Singulair High Risk Populations, J Douglas Bremner, Gayatri Iyer, Neuroscience Research Unit, Leukotriene Receptors
I thought everybody would be interested to know about the researcher from Emory that commented on possible psychiatric side effects of Singulair if leukotriene receptors exist in the brain. Here is a description of his book. I hope that we will hear more from Dr. Bremner. And, no I am not here to promote his book. I just saw this today when I was searching for other information. I was thinking about his quote and wanted to know his background. ... more »
I thought everybody would be interested to know about the researcher from Emory that commented on possible psychiatric side effects of Singulair if leukotriene receptors exist in the brain. Here is a description of his book. I hope that we will hear more from Dr. Bremner. And, no I am not here to promote his book. I just saw this today when I was searching for other information. I was thinking about his quote and wanted to know his background.
Merck’s Singulair likely to see prescription drop-off only in high-risk populations
By Beth Herskovits and Gayatri Iyer in New York
Published: March 28 2008 19:52 | Last updated: March 28 2008 19:52
This article is provided to FT.com readers by Pharmawire—a news service focused on providing insight into the most price sensitive issues in the global pharmaceutical market. www.pharmawire.com
"Dr Douglas Bremner, director of Emory’s Clinical Neuroscience Research Unit, noted that drugs can cause psychiatric effects when the targeted receptor also exists in the brain. But he added that it’s unclear whether the brain has leukotriene receptors.
He noted that despite the updated label, the side effects ”sort of flew below the radar.” However, he painted a grimmer picture of the effect on the market, saying this would affect Singular sales badly. People are likely to stop taking it, he added. "
Before You Take that Pill
Why the Drug Industry May Be Bad for Your Health
J. Douglas Bremner - Author Book: Paperback | 8.26 x 5.23in | 448 pages | ISBN 9781583332955 | 28 Feb 2008 | Avery | Adult
A medical expert reveals risks of the most commonly prescribed drugs-and why the drug industry doesn't want consumers to know about them.
Recent scandals involving diabetes drugs, Vioxx, and many other medications reveal the serious and undisclosed risks of some of the most commonly used prescription drugs in this country. In Before You Take That Pill, Dr. J. Douglas Bremner, a researcher and clinician at Emory University whose study on Accutane and depression made headlines, offers an inside look at the pharmaceutical industry, as well as a scientifically backed assessment of the risks of more than three hundred prescribed medications, vitamins, and supplements.
While many drugs are essential to the health of consumers, as Dr. Bremner explains, for many people, the benefits may not outweigh the potential side effects. This book contains warnings that are not on the drug labels. It also exposes tricks of the trade that demonstrate how the profit-making interests of "big pharma" may not always be in line with the safety of the public - from the corruption that exists in the drug approval process to the tactics drug companies use to encourage doctors to prescribe their products. Most important, Before You Take That Pill empowers readers by giving them sound information on specific medications so they can understand and weigh the potential risk themselves. Backed by the latest studies, as well as insight from a doctor who is in the trenches, this book should be on the shelf of every drug consumer.